Innovative Industrial Properties just might turn things around this year. There hasn't been much good news for Innovative Industrial Properties (IIPR 0.81%) lately. Shares of the cannabis-focused real estate investment trust (REIT) have plunged more than 60% below the peak set in the third quarter of 2024. One of the few bright spots for Innovative Industrial Properties is its dividend, which curr...
Innovative Industrial Properties just might turn things around this year. There hasn't been much good news for Innovative Industrial Properties (IIPR 0.81%) lately. Shares of the cannabis-focused real estate investment trust (REIT) have plunged more than 60% below the peak set in the third quarter of 2024. One of the few bright spots for Innovative Industrial Properties is its dividend, which currently yields an astronomical 15.7%. Could this beaten-down REIT stock provide something other than its dividend for investors to celebrate and soar in 2026? Three positive factors for this cannabis REIT I think there are three positive factors for Innovative Industrial Properties that give investors reason to be cautiously optimistic about 2026. First, analysts project that the company will return to growth this year. Granted, the growth will likely be slight. The consensus revenue estimate of $269.7 million is only around 1.5% above the anticipated revenue for 2025. However, a year-over-year gain is much better than the revenue declines that Innovative has experienced recently. Second, the rescheduling of marijuana to Schedule III could benefit Innovative Industrial Properties in 2026. In particular, rescheduling could help some of the REITs tenants by eliminating Section 280E of the tax code. This section has prevented cannabis operators from deducting standard business expenses. Removal of this limitation would boost marijuana stocks and their financial positions -- along with their ability to pay rents due to Innovative. Third, Innovative Industrial Properties' valuation could look significantly more attractive to investors in a more favorable regulatory climate. The stock trades at 11.4 times forward earnings. Some discounted cash flow models also suggest its intrinsic value is well above the current share price. Expand NYSE : IIPR Innovative Industrial Properties Today's Change ( -0.81 %) $ -0.40 Current Price $ 48.26 Key Data Points Market Cap $1.4B Day's Range $ 47....
亞冠精英聯賽 神戶勝利船2比0擊敗FC首爾 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】亞冠精英聯賽，神戶勝利船主場2比0擊敗FC首爾，提前一輪出線。 棗紅衫勝利船，武藤嘉紀第一腳被擋，加多腳補中，VAR指進攻...
亞冠精英聯賽 神戶勝利船2比0擊敗FC首爾 To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video 【有線新聞】亞冠精英聯賽，神戶勝利船主場2比0擊敗FC首爾，提前一輪出線。 棗紅衫勝利船，武藤嘉紀第一腳被擋，加多腳補中，VAR指進攻過程越位，入球無效。南韓的FC首爾下星期來港出戰賀歲盃，在大球場鬥港隊，69分鐘輸反擊，吃了次「詐糊」的武藤嘉紀推足大半場，禁區射遠柱入網，勝利船先開紀錄。這支日職球隊4分鐘後右路組織，隊長酒井高德後上建功。在日本國家隊監督森保一見證下，勝利船贏2比0，提早一輪鎖定16強席位。
bymuratdeniz/iStock via Getty Images Twist Bioscience's ( TWST ) stock has rebounded sharply in recent months, driven by growing optimism around the impact of AI-enabled drug discovery and MRD testing adoption. Twist's Biopharma segment is reaccelerating, driven by AI-enabled drug discovery customers, and NGS growth is expected to rebound as FY27 progresses, driven by MRD customers. I previously s...
bymuratdeniz/iStock via Getty Images Twist Bioscience's ( TWST ) stock has rebounded sharply in recent months, driven by growing optimism around the impact of AI-enabled drug discovery and MRD testing adoption. Twist's Biopharma segment is reaccelerating, driven by AI-enabled drug discovery customers, and NGS growth is expected to rebound as FY27 progresses, driven by MRD customers. I previously suggested that macro headwinds and temporary challenges in the NGS business were weighing on Twist. The stock is up over 60% since then, with near-term weakness proving less severe than initially expected. While Twist's valuation isn't as compelling now, the stock should still provide strong returns over the next few years, driven by robust growth and improving margins. Increased expectations create the risk of a pullback, but I would view this as a buying opportunity given the strong prospects of the company. Market Conditions Twist has faced a challenging demand environment recently, but there is reason to believe that this situation is beginning to change. In particular, liquid biopsy-related NGS demand is ramping up, and AI is starting to become a tailwind amongst biopharma customers. This is noteworthy, as these are Twist's large end markets by far. While academic customers faced funding constraints in 2025, Twist still managed to generate 13% revenue growth from this segment. Twist is underpenetrated in this area but is growing faster than its competitors. The Industry and Applied segment is likely to remain a weak spot in the near term, but its size limits the importance of this. Figure 2: Twist Bioscience Revenue by End Market (source: Twist Bioscience) Twist's SAM has grown from 2 billion USD in 2020 to 7 billion USD in 2025 and is expected to further expand to 12 billion USD by 2030. NGS is the larger and faster-growing market and is likely to become increasingly dominated by oncology diagnostics in coming years. While this may seem like a relatively modest opportu...
Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha More on BP p.l.c. BP: Questions About The Profitability Of The New Focus BP p.l.c.: Castrol Sale And Implications BP Selling A 65% Stake In Castrol Could Be A Great Move BP p.l.c. declares $0.4992/ADS quarterly dividend, but share buybacks suspen...
Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha Seeking Alpha More on BP p.l.c. BP: Questions About The Profitability Of The New Focus BP p.l.c.: Castrol Sale And Implications BP Selling A 65% Stake In Castrol Could Be A Great Move BP p.l.c. declares $0.4992/ADS quarterly dividend, but share buybacks suspended for 2026 BP beats Q4 top-line estimates; initiates Q1 and FY26 outlook
Japan’s government bonds gained after Prime Minister Sanae Takaichi’s historic election triumph fueled confidence among investors that increased fiscal spending can be digested by the market. Yields declined across the curve, with the biggest drop seen in that of the volatile 40-year tenor, which fell 9 basis points to 3.725%. Yields have now retreated to near levels seen in early January when Tak...
Japan’s government bonds gained after Prime Minister Sanae Takaichi’s historic election triumph fueled confidence among investors that increased fiscal spending can be digested by the market. Yields declined across the curve, with the biggest drop seen in that of the volatile 40-year tenor, which fell 9 basis points to 3.725%. Yields have now retreated to near levels seen in early January when Takaichi’s snap vote was first reported. That triggered a rout in Japanese debt that threatened to destabilize global bond markets. The reaction suggested that some fund managers are ready to give Takaichi the benefit of the doubt for now, betting that her success will allow for clearer policy and lower the risk of worst-case fiscal scenarios. Speaking Monday in a press briefing, the premier vowed to build trust with financial markets as concerns persist over how she’ll pay for a planned tax cut. “The bigger-than-expected victory over the weekend means the Takaichi government will be more fiscally sound,” as it reduces fiscal demands from her coalition party, said Russel Matthews , a senior portfolio manager at RBC BlueBay Asset Management. “We remain positive on the outlook for Japanese government bonds, particularly in the long and ultra-long sectors of the yield curve,” he said. Read more: How Takaichi Won Big in Japan’s Snap Election Yields on both 20- and 30-year bonds also fell around 6 basis points, to about 3.105% and 3.495% respectively, with the Japanese market getting support from US Treasuries . Moves were more pronounced for the 40-year sector, which has seen some wild swings over the past month, in part due to its low liquidity. The drop in yields was less for shorter-tenor notes on speculation the Bank of Japan may raise interest rates again in the months ahead. The swaps market is pricing in a 78% chance of a quarter point increase by the BOJ’s April meeting, and certainty of another hike by June. The yen, meanwhile, strengthened 0.2% to 155.56 against the doll...